BridgeBio Pharma (BBIO) Fair Value & DCF
BBIO$76.52-0.84 -1.09%
Market cap$14.91BEnterprise value$16.13BRevenue (TTM)$945.54MMarket positionTop 25%
Score
56
Neutral
Value
39
Quality
30
Growth
98
BridgeBio Pharma, Inc. (BBIO) trades at $76.52 on $14.91B of equity value, with a trailing P/E of -25.62. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.